TREA

88308511 - PAIGE

Follow

Information

  • Trademark
  • 88308511
  • Serial Number
    88308511
  • Registration Number
    6206397
  • Filing Date
    February 20, 2019
    5 years ago
  • Registration Date
    November 24, 2020
    4 years ago
  • Transaction Date
    March 25, 2022
    2 years ago
  • Status Date
    November 24, 2020
    4 years ago
  • Published for Opposition Date
    July 02, 2019
    5 years ago
  • Location Date
    October 21, 2020
    4 years ago
  • First Use Anywhere Date
    February 21, 2019
    5 years ago
  • First Use In Commerce Date
    February 21, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MORRIS, KRISTINA KLOIB
  • Attorney Docket Number
    121323-60019
    Attorney Name
    Mark Leonardo
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
PAIGE
Case File Statements
  • GS0441: Medical services; cancer therapy services; medical testing, namely, the review and analysis of patients' clinical slides to identify additional recommended medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; providing non-research related medical information via the internet; medical analysis services for the diagnosis of cancer by reviewing pathological samples on slides
  • GS0421: Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes
Case File Event Statements
  • 1/29/2021 - 3 years ago
    49 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/29/2021 - 3 years ago
    48 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/29/2021 - 3 years ago
    47 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/29/2021 - 3 years ago
    46 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/29/2021 - 3 years ago
    45 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/24/2020 - 4 years ago
    44 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/22/2020 - 4 years ago
    43 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 10/21/2020 - 4 years ago
    42 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 10/21/2020 - 4 years ago
    41 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/21/2020 - 4 years ago
    40 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/13/2020 - 4 years ago
    39 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/13/2020 - 4 years ago
    38 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/13/2020 - 4 years ago
    37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/13/2020 - 4 years ago
    36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/13/2020 - 4 years ago
    35 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/13/2020 - 4 years ago
    34 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/11/2020 - 4 years ago
    33 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/11/2020 - 4 years ago
    32 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/11/2020 - 4 years ago
    31 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 8/13/2020 - 4 years ago
    30 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 7/31/2020 - 4 years ago
    29 - USE AMENDMENT FILED Type: IUAF
  • 8/12/2020 - 4 years ago
    28 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/31/2020 - 4 years ago
    27 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 7/8/2020 - 4 years ago
    26 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/8/2020 - 4 years ago
    25 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/8/2020 - 4 years ago
    24 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/8/2020 - 4 years ago
    23 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/8/2020 - 4 years ago
    22 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/24/2020 - 4 years ago
    21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/22/2020 - 4 years ago
    20 - EXTENSION 1 GRANTED Type: EX1G
  • 4/22/2020 - 4 years ago
    19 - EXTENSION 1 FILED Type: EXT1
  • 4/22/2020 - 4 years ago
    18 - TEAS EXTENSION RECEIVED Type: EEXT
  • 10/22/2019 - 5 years ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/11/2019 - 5 years ago
    16 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 8/14/2019 - 5 years ago
    15 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/14/2019 - 5 years ago
    14 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/31/2019 - 5 years ago
    13 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 7/2/2019 - 5 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/2/2019 - 5 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/12/2019 - 5 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/29/2019 - 5 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 5/15/2019 - 5 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/15/2019 - 5 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/15/2019 - 5 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/15/2019 - 5 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/15/2019 - 5 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/1/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/12/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/23/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP